Free Trial

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

Sonnet BioTherapeutics logo
$1.20 -0.10 (-7.69%)
Closing price 03:59 PM Eastern
Extended Trading
$1.21 +0.01 (+0.83%)
As of 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sonnet BioTherapeutics SEC Filings

DateFilerForm TypeView
04/04/2025
8:07 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:03 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:11 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
8:03 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
8:05 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:48 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:15 PM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
7:09 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2025
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
02/02/2025
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
01/31/2025
3:56 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
01/31/2025
3:57 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
01/30/2025
4:25 PM
Sonnet BioTherapeutics (Filer)
Form S-1/A
01/30/2025
4:25 PM
Sonnet BioTherapeutics (Filer)
Form S-1/A
01/28/2025
8:10 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
01/21/2025
8:17 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 424B3
01/13/2025
3:34 PM
Sonnet BioTherapeutics (Filer)
Form POS AM
12/23/2024
3:05 PM
Sonnet BioTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/17/2024
8:00 AM
Sonnet BioTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/17/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:25 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:20 AM
Sonnet BioTherapeutics (Filer)
Form 424B5
12/09/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
8:55 PM
Cross John Harry III (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM
Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
8:20 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:15 PM
Sonnet BioTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/08/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form 424B4
11/06/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
11/06/2024
8:22 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
11/06/2024
7:48 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1/A
10/28/2024
8:01 AM
Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/17/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:56 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:15 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:30 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM
Sonnet BioTherapeutics (Filer)
Form DEF 14A
08/19/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form ARS
08/19/2024
7:50 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:41 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:45 AM
Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
4:28 PM
Sonnet BioTherapeutics (Filer)
Form PRE 14A
07/24/2024
7:36 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Sonnet BioTherapeutics (Filer)
Form EFFECT
07/15/2024
4:05 PM
Sonnet BioTherapeutics (Filer)
Form 424B3
07/05/2024
3:06 PM
Sonnet BioTherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/20/2024
3:49 PM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:15 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:35 AM
Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SONN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners